Biovista Inc

05/21/2025

🎉 We are excited to announce the integration of the MATISSE pocket binding similarity algorithm (by SoftMining) into Biovista Vizit! 🎉

MATISSE uses short (MD) simulations to uncover the flexible nature of active sites, enabling advanced structured-based analyses.

Biovista Vizit now offers integrative workflows that enable more sophisticated hashtag scenarios, e.g:

-Start from a target of interest
-Explore related PDB structures
-Expand across structurally similar binding pockets—even across unrelated proteins
-Discover and repurpose compounds linked to those structures
-Visualize them in 3D via integrated Mol Viewer links

This is Vizit’s fourth corpus integration, following , , and hashtag , and a significant step towards deeper, structure-based drug discovery and drug repurposing workflows.

This technology preview is the result of the ongoing collaboration between Biovista and SoftMining, and is co-funded by the EU Project NewRoad.

https://www.biovista.com/biovista-vizit-new-corpus-matisse-a-softmining-algorithm/

By Eftychia Lekka and Vassilis Virvilis The latest release of Biovista Vizit (May 2025) brings the integration of the MATISSE pocket binding similarity algorithm by SoftMining. MATISSE is a dynamic binding pocket analysis tool that uses short molecular dynamics (MD) simulations to capture the flexib...

05/21/2025

Biovista is a proud contributor to the newly-published paper:

"Building an Adverse Outcome Pathway Network for ."

This international collaborative effort aimed to organize COVID-19 pathogenesis hashtag into a comprehensive (AOP) network, highlighting the central role of and the need for tissue/organ specificity, , and adherence to principles.

This study also provided specific recommendations for future research in -related building.

A big THANK YOU and congratulations to all the brilliant collaborators!

https://www.frontiersin.org/journals/systems-biology/articles/10.3389/fsysb.2024.1384481/full

The COVID-19 pandemic generated large amounts of data on the disease pathogenesis leading to a need for organizing the vast knowledge in a succinct manner. B...

05/21/2025

Excited to announce the integration of (HPO) from The Monarch Initiative into Biovista Vizit!

Following the integration of (AOP) and (PDB), it is the HPO annotations that you can explore visually and review the underlying supporting evidence.

Explore more here:

The latest release of Biovista Vizit brings the integration of Human Phenotype Ontology annotations into the Vizit Knowledge Graph.

05/21/2025

🔬 Biovista Vizit- Latest Releases

The latest update to Biovista Vizit is LIVE, bringing improved capabilities for 🧫:

Updated Corpora: Now includes 2025 versions of: , (PDB) and (AOP). Provide sentence-based sub-corpora for MEDLINE & AOP that offer a more refined view of the supporting evidence.

Enhanced Data Integration: Streamlined ( phenotypes added to ) and (including ) for more comprehensive relationship mapping

Updated : Now offers valuable insights with links to terms from GeneRIF, GeneToPubmed and MeSH Terms.

🧪 Maximize the impact of your research with these powerful new features!

Explore the new release here: https://www.biovista.com/vizit/

Biovista Vizit is a visual exploration tool for biomedical literature based on NCBI PubMed. Vizit allows scientists to search and explore a biomedical domain, such as a disease, a pathway or a gene, and to create biomedical networks and graphs.

05/21/2025

🚀 Unlock Hidden Insights with Biovista Vizit AOP-Powered Analytics!

This release of Biovista Vizit is a game-changer for (AOP) analysis!

With our latest TextScan engine integration, researchers can now extract previously inaccessible insights from the free text of AOPKB corpus, enriching structured and enabling better elucidation, and assessment.

🔍 What’s New?
✅ AI-driven extraction of entities &
✅ Enhanced tagging of key , , and
✅ Deeper, mechanism-based understanding of

📢 Ready to harness AOP data visualization? Start here:
https://aopkb.biovista.com/ #!bv_gid=c54811ed6f5b484de2094e9859a7e0e3

More on this release: https://www.biovista.com/biovista-vizit-january-2025-release-aop-features/

The latest release of Biovista Vizit (January 2025) brings a few precious features especially relevant to our AOP users

10/04/2023

We are happy to announce that the AOP-KB-based Vizit installation in the AOP-Wiki has been updated to host the latest data. Vizit is the easiest way to explore and create visually interactive of AOPs, KEs and their components, including associations. Explore Vizit in the AOP-Wiki 3rd Party Tool Webpage: https://aopkb.biovista.com/ #!bv_gid=ee5c4ccab417deae317653733cbe82ac

06/20/2022

Biovista's Eftychia Lekka and Vassilis Virvilis will be presenting at the National Institutes of Health (NIH) Predictive Division ( ) Seminar, a systematic approach on reviewing and categorizing user-entered issues in the ( ) Framework, using the project (https://www.ciao-covid.net/) as a showcase. The presentation will touch upon possible suggestions on different levels and present a visualization system that exposes the above-mentioned issues and connects to external data sources ( ). https://www.biovista.com/biovista-presentation-in-nih-predictive-toxicology-branch-dntp/

11/17/2021

The Wnt & β-Catenin Targeted is on! Aris Persidis' presentation "Seeing Wnt/β-Catenin Through the Lens of should not be missed!

09/29/2020

Biovista president Aris Persidis is presenting at the upcoming Data Analytics and -19 Pandemic SAS Virtual Symposium organized by Oakland University's Center for and . Don't miss out on excellent speakers on Friday, October 2, 2020!

Center for Data Science and Big Data Analytics, Big Data, Data Science, Analytics, Data Analytics

09/18/2020

Aris Persidis will speak at the Annual Drug Repositioning, Repurposing and Rescue Conference

Arrowhead's 7th Annual Drug Repositioning, Repurposing and Rescue Conference will highlight tool sets for identifying repositioning opportunities as well as the technical, regulatory and intellectual property challenges that arise.

04/23/2020

Biovista's integrative approach based on our Artificial Intelligence platform and expert team curation has identified four repositioned drugs that could show promise against .

/PRNewswire/ -- Biovista, a privately-held AI / bioscience firm best known for drug repositioning, has identified four treatments – two prescription drugs and...